Literature DB >> 24209806

Dexmedetomidine regulates inflammatory molecules contributing to ventilator-induced lung injury in dogs.

Chang Chen1, Zongze Zhang2, Kai Chen1, Fan Zhang3, Mian Peng1, Yanlin Wang1.   

Abstract

BACKGROUND: Dexmedetomidine reduced mortality and inhibited the inflammatory response during endotoxemia in rats. The aim of this study was to clarify the effect of dexmedetomidine-regulating inflammation on a noninfectious, ventilator-induced lung injury (VILI) in dogs.
METHODS: Thirty healthy Beagles weighing between 8 and 12 kg were randomly divided into five groups: control group (group C, n = 6), mechanical ventilation (group MV, n = 6), and three different doses of dexmedetomidine group (group DEX1-3, n = 6). VILI was induced by high-tidal volume ventilation (tidal volume 20 mL/kg; respiratory rate 15 breaths/min; FiO2 0.5). Group DEX received intravenous Dex 20 min before endotracheal intubation (0.5, 1.0, and 2.0 μg/kg Dex was infused within 20 min and then a maintenance dose of 0.5, 1.0, and 2.0 μg/kg/h Dex was infused intravenously). Arterial blood samples were obtained from femoral artery at base state, MV1h, MV2h, and MV4h for blood gas analysis. After being mechanically ventilated for 4 h, dogs were killed and the levels of pulmonary inflammatory response and polymorphonuclear neutrophils (PMNs) count in bronchoalveolar lavage fluid were evaluated.
RESULTS: Histologic findings of the MV, DEX1, DEX2, and DEX3 groups revealed severe, moderate, mild, and normal to minimal inflammation, respectively. Myeloperoxidase level, PMNs/alveoli ratio, nuclear factor-κB messenger RNA (mRNA), tumor necrosis factor-alpha mRNA, and inducible nitric oxide synthase mRNA expression in lung tissues of the DEX2 and DEX3 were significantly lower than those of the MV group. Partial pressures of oxygen was decreased significantly at MV4h as compared with the baseline. There was no statistical significance in partial pressures of oxygen between MV and DEX2 group as well as between group MV and group DEX3.
CONCLUSIONS: Dexmedetomidine could mitigate pulmonary inflammatory response induced by VILI in dogs.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dexmedetomidine; Inflammatory factor; Ventilator-induced lung injury; α2-adrenergic receptors

Mesh:

Substances:

Year:  2013        PMID: 24209806     DOI: 10.1016/j.jss.2013.09.018

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  11 in total

1.  Dexmedetomidine reduces ventilator-induced lung injury (VILI) by inhibiting Toll-like receptor 4 (TLR4)/nuclear factor (NF)-κB signaling pathway.

Authors:  Hongli Chen; Xiaotong Sun; Xiaomei Yang; Yonghao Hou; Xiaoqian Yu; Yang Wang; Jianbo Wu; Dejie Liu; Huanliang Wang; Jingui Yu; Wenbo Yi
Journal:  Bosn J Basic Med Sci       Date:  2018-05-20       Impact factor: 3.363

2.  [Protective effects of dexmedetomidine against pulmonary ischemia-reperfusion injury during cardiopulmonary bypass in rats].

Authors:  Ge Cao; Eryong Zhang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-08-30

3.  Effect of dexmedetomidine on myocardial ischemia-reperfusion injury.

Authors:  Shoulin Chen; Fuzhou Hua; Jun Lu; Yu Jiang; Yanhua Tang; Lei Tao; Bing Zou; Qinghua Wu
Journal:  Int J Clin Exp Med       Date:  2015-11-15

4.  Dexmedetomidine Analgesia Effects in Patients Undergoing Dental Implant Surgery and Its Impact on Postoperative Inflammatory and Oxidative Stress.

Authors:  Sisi Li; Yang Yang; Cong Yu; Ying Yao; Yujia Wu; Lian Qian; Chi Wai Cheung
Journal:  Oxid Med Cell Longev       Date:  2015-06-15       Impact factor: 6.543

5.  Dexmedetomidine: Current Role in Burn ICU.

Authors:  G Scibelli; L Maio; M Sasso; A Lanza; G Savoia
Journal:  Transl Med UniSa       Date:  2017-07-01

6.  Dexmedetomidine attenuates lipopolysaccharide-induced acute lung injury by inhibiting oxidative stress, mitochondrial dysfunction and apoptosis in rats.

Authors:  Chunlai Fu; Xingui Dai; You Yang; Mengxiang Lin; Yeping Cai; Shaoxi Cai
Journal:  Mol Med Rep       Date:  2016-12-09       Impact factor: 2.952

7.  α2-adrenoreceptor modulated FAK pathway induced by dexmedetomidine attenuates pulmonary microvascular hyper-permeability following kidney injury.

Authors:  Qian Chen; Bin Yi; Jianbo Ma; Jiaoling Ning; Lingzhi Wu; Daqing Ma; Kaizhi Lu; Jianteng Gu
Journal:  Oncotarget       Date:  2016-08-30

8.  The effect of dexmedetomidine and clonidine on the inflammatory response in critical illness: a systematic review of animal and human studies.

Authors:  Charles A Flanders; Alistair S Rocke; Stuart A Edwardson; J Kenneth Baillie; Timothy S Walsh
Journal:  Crit Care       Date:  2019-12-11       Impact factor: 9.097

9.  Dexmedetomidine reduces ventilator-induced lung injury via ERK1/2 pathway activation.

Authors:  Chun-Hua Zhu; Jian Yu; Ben-Qing Wang; Yu Nie; Lei Wang; Shi-Qiang Shan
Journal:  Mol Med Rep       Date:  2020-10-19       Impact factor: 2.952

10.  Dexmedetomidine: another arrow in the quiver to fight COVID-19 in intensive care units.

Authors:  Amit Jain; Massimo Lamperti; D John Doyle
Journal:  Br J Anaesth       Date:  2020-10-14       Impact factor: 9.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.